Results 81 to 90 of about 4,418 (114)

Anti‐CD20 monoclonal antibody therapy in multiple myeloma

British Journal of Haematology, 2008
Prashant Kapoor, Patricia T Greipp, S Vincent Rajkumar   +2 more
exaly  

CD20: A target antigen for immunotherapy of autoimmune diseases

Autoimmunity Reviews, 2005
Federico Perosa, Elvira Favoino, Franco Dammacco   +2 more
exaly  

CD20 antibodies

2018
LEUSEN JEANNETTE HENRICA WILHELMINA, BOROSS PETER, JANSEN JOHANNES HENDRIK MARCO, MEYER SASKIA   +3 more
openaire   +3 more sources

CD20

2016
openaire   +1 more source

CD20.

Journal of biological regulators and homeostatic agents, 2003
P J, Macardle, I C, Nicholson
openaire   +1 more source

Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells

Acta Pharmacologica Sinica, 2017
Yingying Zhang, Zhang Ying-Ying
exaly  

TRUNCATED CD20 PROTEIN , DELTA CD20

2010
FERRAND CHRISTOPHE, DESCHAMPS MARINA, HENRY CAROLE, TIBERGHIEN PIERRE, BORG CHRISTOPHE, ROHRLICH PIERRE-SIMON   +5 more
openaire   +4 more sources

Cd20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes

Cytometry, 1993
J V Giorgi, L E Hultin
exaly  

B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis

Proceedings of the National Academy of Sciences of the United States of America, 2020
Martin Weber, Sebastian Torke, Wolfgang Bruck   +2 more
exaly  

CD20

2006
openaire   +1 more source